Director/PDMR Shareholding
EDX Medical Group PLC announced that its Chairman, Jason Holt, purchased a total of 200,000 ordinary shares on January 5, 2026, at an average price of 11.42 pence per share, comprising 150,000 shares at 11.23 pence and 50,000 shares at 12.00 pence. Following these transactions, Mr. Holt now holds 4,600,000 shares, representing 1.19% of the company's issued share capital.
Select text to share a quote on X · sign in to keep highlights & notes in your EDX notes
CAMBRIDGE, UK: EDX Medical Group, plc ("EDX Medical", the "Company" or the "Group"), which develops innovative digital diagnostic products and services for the personalised treatment for cancer, heart disease and infectious diseases, today announces that Jason Holt, chairman of the Company, purchased 150,000 ordinary shares in the Company at a price per share of 11.23 pence, followed by a further 50,000 ordinary shares in the Company at a price per share of 12.00 pence on January 5, 2026.
Taken together, a total of 200,000 shares was purchased at an average price per share of 11.42 pence.
Following these transactions, Mr Holt now owns 4,600,000 shares in the Company, representing 1.19% of the issued share capital.
The directors of the Company accept responsibility for the contents of this announcement.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |
| a) | Name | Jason Holt |
| 2 | Reason for the notification | |
| a) | Position/status | Company Chairman |
| b) | Initial notification /Amendment | Initial notification |
| a) | Name | EDX Medical Group PLC |
| b) | LEI | 213800BZVJZTMCZ6DJ63 |
| a) | Description of the financial instrument, type of instrument | Ordinary Shares of £0.01 each |
| Identification code | ISIN: GB00BNDMJS47 | |
| b) | Nature of the transaction | Purchase of shares on market |
| c) | Price(s) and volume(s) | |
| Price | Volume | |
| £0.1123 | 150,000 | |
| £0.1200 | 50,000 | |
| d) | Aggregated information | |
| - Aggregated volume | 200,000 | |
| - Price | £0.1142 | |
| e) | Date of the transaction | 2026-01-02 2026-01-05 |
| f) | Place of the transaction | AQSG - Aquis Growth Market (Equity) |
- Commission Delegated Regulation (EU) 2016/522 of 17 December 2015 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council as regards an exemption for certain third countries public bodies and central banks, the indicators of market manipulation, the disclosure thresholds, the competent authority for notifications of delays, the permission for trading during closed periods and types of notifiable managers' transactions (see page 1 of this Official Journal).
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.